20th Maui Cardiovascular Symposium
Agenda
| Thursday, October 14, 2021 | ||
|---|---|---|
| 12:00-1:00 PM | Registration | Pikake Foyer |
| 1:00-1:10 PM | Aloha and Introductory Remarks | John Gordon, MD |
| 1:10-1:15 PM | Welcome from the California Chapter, ACC | Dipti Itchhaporia, MD |
| 1:15-1:45 PM | Corona Virus and the Heart: Case Study Manifestations and Therapies | Brian Jaski, MD |
| 1:45-2:15 PM | What COVID-19 Can Teach Us About Kawasaki Disease | Jane Burns, MD |
| 2:15-2:45 PM | Salt and Cardiovascular Disease: Friend or Enemy? | Richard Wright, MD |
| 2:45-3:15 PM | Opening The “Window of Opportunity” To Optimize Cardiovascular Health in Women | Cindy Stuenkel, MD |
| 3:15-3:30 PM | Discussion / Break / Exhibits | Hibiscus Room |
| 3:30-4:00 PM | The Ischemia Trial: Decisive, Divisive, or Does It Matter? | Mitul Patel, MD |
| 4:00-4:30 PM | Evolving Role of the Cardiologist in the Care of Diabetes | Matthew Budoff, MD |
| 4:30-5:00 PM | Evolving Mitral Valve Repair and Replacement Options- What Is The Best approach? | Christian Spies, MD |
| 5:00-6:00 PM | RECEPTION | Royal Fountain Terrace |
| Friday, October 15, 2021 | ||
| 7:00-7:30 AM | Continental Breakfast | Hibiscus Room |
| 7:30-7:35 AM | Welcome and Announcements | John Gordon, MD |
| 7:35-8:05 AM | New Lipid Therapies in 2021 | Matthew Budoff, MD |
| 8:05-8:35 AM | Renal Artery Stenosis: Hemodynamic Assessment and Role in HTN Management | Dipti Itchhaporia, MD |
| 8:35-9:05 AM | Novel Approaches To Treatment Of Persistent Atrial Fibrillation | Charles Athill, MD |
| 9:05-9:35 AM | VEST Trial and Registry: What Did We Learn? | Byron Lee, MD |
| 9:35-10:05 AM | Sleep Apnea: Can We Prevent Cardiovascular Complications of Disordered Sleep? | Atul Malhotra, MD |
| 10:05-10:15 AM | Discussion / Break / Exhibits | Hibiscus Room |
| 10:15-10:45 AM | What Is The Best Therapy For Preventing Stroke In patients with Atrial Fibrillation? | Shephal Doshi, MD |
| 10:45-11:15 AM | Antiplatelet Therapy For PCI in ACS Patients Requiring Oral Anticoagulation: Changing Strategies In Management | Ralph Brindis, MD |
| 11:15-12:00 PM | TAVR vs SAVR: Which Patients Still Need Open Aortic Valve Surgery? | Arvin Narula, MD Robert Adamson, MD |
| 1:00-5:00 PM | Coronary and Vascular Disease Workshops (Non-CME) | John Gordon, MD Robert Adamson, MD |
| 6:30- 9:30 PM | Great Cases Dinner (Non-CME) | Lobby Mezzanine |
| Saturday, October 16, 2021 | ||
| 7:00-7:30 AM | Continental Breakfast | Hibiscus Room |
| 7:30-7:35 AM | Welcome and Announcements | John Gordon, MD |
| 7:35-8:05 AM | ACC/AHA Guideline for the Primary Prevention of Cardiovascular Disease | Sidney Smith, MD |
| 8:05-8:35 AM | Cardiogenic Shock: How Can We Improve Outcomes? | Niraj Parekh, MD |
| 8:35-9:05 AM | Endovascular vs Open Repair For Aneurysmal Disease Of The Aorta: Long Term Outcomes | Robert Adamson, MD |
| 9:05-9:45 AM | Device Detected Atrial Fibrillation: Should Episodes Less Than One Hour Be Anticoagulated? | Jonathan Lowy, MD |
| 9:45-10:30 AM | Critical Limb Ischemia 2020: What We Know And What We Still Need To Learn | Kenneth Rosenfield, MD |
| 10:30-10:45 AM | Discussion / Break / Exhibits | Hibiscus Room |
| 10:45-11:15 AM | Cardiomyopathy and the Heart: Amyloid | Richard Wright, MD |
| 11:15-11:45 AM | Improving Cardiac Response Rates With Cardiac Resyncronization Therapy | John McKenzie, MD |
| 11:45-12:30 PM | Kawasaki Disease: Long Term Outcomes | John Gordon, MD Jane Burns, MD |
| 1:00-4:50 PM | Arrhythmia Management Workshops(Non-CME) | Charles Athill, MD Jonathan Lowy, MD |
| 4:50-5:00 PM | Concluding Remarks | John Gordon, MD |